Package 71610-164-83

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 71610-164-83
Digits Only 7161016483
Product NDC 71610-164
Product ID 71610-164_98de55f8-557e-4e9a-b959-03ac0945da0f
Description

3600 TABLET, FILM COATED in 1 BOTTLE (71610-164-83)

Marketing

Marketing Status
Marketed Since 2018-09-26
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "98de55f8-557e-4e9a-b959-03ac0945da0f", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687"], "spl_set_id": ["7d81ed30-ddf7-431a-84f8-6c630cf2b977"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "3600 TABLET, FILM COATED in 1 BOTTLE (71610-164-83)", "package_ndc": "71610-164-83", "marketing_start_date": "20180926"}], "brand_name": "Bupropion Hydrochloride", "product_id": "71610-164_98de55f8-557e-4e9a-b959-03ac0945da0f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71610-164", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA076143", "marketing_category": "ANDA", "marketing_start_date": "20060117", "listing_expiration_date": "20261231"}